Zhejiang Zhenyuan Share Co.,Ltd. (SHE:000705)
8.24
-0.02 (-0.24%)
May 6, 2026, 3:05 PM CST
Zhejiang Zhenyuan Share Revenue
Zhejiang Zhenyuan Share had revenue of 440.52M CNY in the quarter ending March 31, 2026, a decrease of -41.39%. This brings the company's revenue in the last twelve months to 1.96B, down -43.02% year-over-year. In the year 2025, Zhejiang Zhenyuan Share had annual revenue of 2.28B, down -39.17%.
Revenue (ttm)
1.96B
Revenue Growth
-43.02%
P/S Ratio
1.40
Revenue / Employee
947.64K
Employees
2,073
Market Cap
2.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.28B | -1.47B | -39.17% |
| Dec 31, 2024 | 3.74B | -365.68M | -8.91% |
| Dec 31, 2023 | 4.11B | -39.11M | -0.94% |
| Dec 31, 2022 | 4.15B | 533.43M | 14.77% |
| Dec 31, 2021 | 3.61B | 172.20M | 5.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.96B |
| Zhejiang Int'l Group | 33.84B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.90B |
| Hangzhou Minsheng Healthcare | 827.65M |
| Chongqing Lummy Pharmaceutical | 759.50M |
| Hubei Guangji Pharmaceutical | 638.58M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Haisen Pharmaceutical | 520.97M |